Tivozanib OverviewTivozanib, sold under the brand name Fotivda, is a medication used for the treatment of relapsed or refractory advanced renal cell carcinoma (RCC). It is an oral VEGF receptor tyrosine kinase inhibitor. It was discovered by Kyowa Kirin and developed by AVEO Pharmaceuticals. The most common side effects include fatigue, hypertension, diarrhea, decreased appetite, nausea, dysphonia, hypothyroidism, cough, and stomatitis....
Read more Tivozanib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tivozanib
Recent Tivozanib Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 0.89mg, 1.34mg
Other drugs which contain Tivozanib or a similar ingredient: (1 result)
- FOTIVDA Tivozanib Hydrochloride